Ca2+-dependent modulation of voltage-gated myocyte sodium channels.
View / Open Files
Authors
Salvage, Samantha C
Habib, Zaki F
Matthews, Hugh R
Jackson, Antony P
Huang, Christopher L-H
Publication Date
2021-10-13Journal Title
Biochemical Society Transactions
ISSN
0300-5127
Publisher
Portland Press
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Salvage, S. C., Habib, Z. F., Matthews, H. R., Jackson, A. P., & Huang, C. L. (2021). Ca2+-dependent modulation of voltage-gated myocyte sodium channels.. Biochemical Society Transactions https://doi.org/10.1042/BST20200604
Abstract
Voltage-dependent Na+ channel activation underlies action potential generation fundamental to cellular excitability. In skeletal and cardiac muscle this triggers contraction via ryanodine-receptor (RyR)-mediated sarcoplasmic reticular (SR) Ca2+ release. We here review potential feedback actions of intracellular [Ca2+] ([Ca2+]i) on Na+ channel activity, surveying their structural, genetic and cellular and functional implications, translating these to their possible clinical importance. In addition to phosphorylation sites, both Nav1.4 and Nav1.5 possess potentially regulatory binding sites for Ca2+ and/or the Ca2+-sensor calmodulin in their inactivating III-IV linker and C-terminal domains (CTD), where mutations are associated with a range of skeletal and cardiac muscle diseases. We summarize in vitro cell-attached patch clamp studies reporting correspondingly diverse, direct and indirect, Ca2+ effects upon maximal Nav1.4 and Nav1.5 currents (Imax) and their half-maximal voltages (V1/2) characterizing channel gating, in cellular expression systems and isolated myocytes. Interventions increasing cytoplasmic [Ca2+]i down-regulated Imax leaving V1/2 constant in native loose patch clamped, wild-type murine skeletal and cardiac myocytes. They correspondingly reduced action potential upstroke rates and conduction velocities, causing pro-arrhythmic effects in intact perfused hearts. Genetically modified murine RyR2-P2328S hearts modelling catecholaminergic polymorphic ventricular tachycardia (CPVT), recapitulated clinical ventricular and atrial pro-arrhythmic phenotypes following catecholaminergic challenge. These accompanied reductions in action potential conduction velocities. The latter were reversed by flecainide at RyR-blocking concentrations specifically in RyR2-P2328S as opposed to wild-type hearts, suggesting a basis for its recent therapeutic application in CPVT. We finally explore the relevance of these mechanisms in further genetic paradigms for commoner metabolic and structural cardiac disease.
Keywords
C-terminal domain, ca2+, cardiac arrhythmia, cardiomyocytes, skeletal myocytes, sodium channels
Sponsorship
Medical Research Council (MR/M001288/1)
British Heart Foundation (None)
Wellcome Trust (105727/Z/14/Z)
British Heart Foundation (PG/19/59/34582)
Biotechnology and Biological Sciences Research Council (BB/J021091/1)
Identifiers
External DOI: https://doi.org/10.1042/BST20200604
This record's URL: https://www.repository.cam.ac.uk/handle/1810/329925
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk